12:31 EDT Phathom jumps 124% to $10.49 after FDA corrects Voquenza exclusivity
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PHAT:
- Largest borrow rate increases among liquid names
- Biotech Alert: Searches spiking for these stocks today
- Phathom Pharmaceuticals price target lowered to $12 from $18 at Guggenheim
- Phathom Pharmaceuticals price target lowered to $20 from $28 at H.C. Wainwright
- Phathom Pharmaceuticals Reports Q1 2025 Financial Results